These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 19800119

  • 1. High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia.
    Jeddi R, Ghédira H, Mnif S, Gouider E, Fenaux P, Meddeb B.
    Leuk Res; 2010 Apr; 34(4):545-7. PubMed ID: 19800119
    [Abstract] [Full Text] [Related]

  • 2. Treatment of acute promyelocytic leukemia with PETHEMA LPA 99 protocol: a Tunisian single center experience.
    Jeddi R, Ghédira H, Menif S, Ben Neji H, Ben Amor R, Kacem K, Aissaoui L, Bouteraâ W, Abdennebi Y, Raihane BL, Gouider E, Raouf H, Hèla BA, Saad A, Zaher B, Meddeb B.
    Hematology; 2010 Aug; 15(4):204-9. PubMed ID: 20670478
    [Abstract] [Full Text] [Related]

  • 3. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Aug; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 4. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
    Ortega JJ, Madero L, Martín G, Verdeguer A, García P, Parody R, Fuster J, Molines A, Novo A, Debén G, Rodríguez A, Conde E, de la Serna J, Allegue MJ, Capote FJ, González JD, Bolufer P, González M, Sanz MA, PETHEMA Group.
    J Clin Oncol; 2005 Oct 20; 23(30):7632-40. PubMed ID: 16234524
    [Abstract] [Full Text] [Related]

  • 5. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.
    Kelaidi C, Chevret S, De Botton S, Raffoux E, Guerci A, Thomas X, Pigneux A, Lamy T, Rigal-Huguet F, Meyer-Monard S, Chevallier P, Maloisel F, Deconinck E, Ferrant A, Fegueux N, Ifrah N, Sanz M, Dombret H, Fenaux P, Adès L.
    J Clin Oncol; 2009 Jun 01; 27(16):2668-76. PubMed ID: 19414681
    [Abstract] [Full Text] [Related]

  • 6. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J, Shen ZX, Sun GL, Chen SJ, Wang ZY, Chen Z.
    Int J Hematol; 1999 Dec 01; 70(4):248-60. PubMed ID: 10643151
    [Abstract] [Full Text] [Related]

  • 7. Management of acute promyelocytic leukemia relapse in the ATRA era.
    Castagnola C, Lunghi M, Corso A, Tajana M, Zappasodi P, Dabusti M, Lazzarino M, Bernasconi C.
    Haematologica; 1998 Aug 01; 83(8):714-7. PubMed ID: 9793255
    [Abstract] [Full Text] [Related]

  • 8. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy.
    Serefhanoglu S, Buyukasik Y, Goker H, Sayinalp N, Haznedaroglu IC, Aksu S, Ozcebe OI, Turgut M, Aslan R, Ozdemir E.
    Leuk Res; 2010 Dec 01; 34(12):e317-9. PubMed ID: 20696473
    [No Abstract] [Full Text] [Related]

  • 9. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA, Rose AB, Felice MS, Alfaro E, Delfino S, Cygler AM, Sackmann-Muriel F.
    Pediatr Hematol Oncol; 2000 Mar 01; 17(2):155-62. PubMed ID: 10734658
    [Abstract] [Full Text] [Related]

  • 10. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
    Dai CW, Zhang GS, Shen JK, Zheng WL, Pei MF, Xu YX, Cao YX, Yi Y, Yang JJ, Peng HL, Zhong HY, Li RJ.
    Acta Haematol; 2009 Mar 01; 121(1):1-8. PubMed ID: 19246888
    [Abstract] [Full Text] [Related]

  • 11. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb 01; 9(1):28-33. PubMed ID: 17306073
    [Abstract] [Full Text] [Related]

  • 12. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
    Xin L, Wan-jun S, Zeng-jun L, Yao-zhong Z, Yun-tao L, Yan L, Chang-chun W, Qiao-chuan L, Ren-chi Y, Ming-zhe H, Jian-xiang W, Lu-gui Q.
    Leuk Res; 2007 Jun 01; 31(6):765-71. PubMed ID: 17007927
    [Abstract] [Full Text] [Related]

  • 13. [Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors].
    Schwarz J, Korístek Z, Starý J, Zák P, Kozák T, Marková J, Michalová K, Dvoráková D, Mayer J, Cetkovský P.
    Vnitr Lek; 2008 Jun 01; 54(7-8):757-70. PubMed ID: 18780575
    [Abstract] [Full Text] [Related]

  • 14. Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia.
    Jeddi R, Kacem K, Ben Neji H, Mnif S, Gouider E, Aissaoui L, Ben Amor R, Ben Lakhal R, Ben Abid H, Belhadjali Z, Meddeb B.
    Hematology; 2008 Jun 01; 13(3):142-6. PubMed ID: 18702871
    [Abstract] [Full Text] [Related]

  • 15. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D, Chelghoum Y, Le QH, Elhamri M, Michallet M, Thomas X.
    Ann Hematol; 2003 Nov 01; 82(11):684-90. PubMed ID: 12928754
    [Abstract] [Full Text] [Related]

  • 16. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.
    de Botton S, Coiteux V, Chevret S, Rayon C, Vilmer E, Sanz M, de La Serna J, Philippe N, Baruchel A, Leverger G, Robert A, San Miguel J, Conde E, Sotto JJ, Bordessoule D, Fegueux N, Fey M, Parry A, Chomienne C, Degos L, Fenaux P.
    J Clin Oncol; 2004 Apr 15; 22(8):1404-12. PubMed ID: 15084614
    [Abstract] [Full Text] [Related]

  • 17. Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia.
    Leblebjian H, DeAngelo DJ, Skirvin JA, Stone RM, Wadleigh M, Werner L, Neuberg DS, Bartel S, McDonnell AM.
    Leuk Res; 2013 Jul 15; 37(7):747-51. PubMed ID: 23643326
    [Abstract] [Full Text] [Related]

  • 18. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
    Thirugnanam R, George B, Chendamarai E, Lakshmi KM, Balasubramanian P, Viswabandya A, Srivastava A, Chandy M, Mathews V.
    Biol Blood Marrow Transplant; 2009 Nov 15; 15(11):1479-84. PubMed ID: 19822309
    [Abstract] [Full Text] [Related]

  • 19. Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
    Adès L, Chevret S, Raffoux E, de Botton S, Guerci A, Pigneux A, Stoppa AM, Lamy T, Rigal-Huguet F, Vekhoff A, Meyer-Monard S, Maloisel F, Deconinck E, Ferrant A, Thomas X, Fegueux N, Chomienne C, Dombret H, Degos L, Fenaux P, European Acute Promyelocytic Leukemia Group.
    J Clin Oncol; 2006 Dec 20; 24(36):5703-10. PubMed ID: 17116939
    [Abstract] [Full Text] [Related]

  • 20. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.
    Hernández JM, Martín G, Gutiérrez NC, Cervera J, Ferro MT, Calasanz MJ, Martínez-Climent JA, Luño E, Tormo M, Rayón C, Díaz-Mediavilla J, González M, González-San Miguel JD, Pérez-Equiza K, Rivas C, Esteve J, Alvarez Mdel C, Odriozola J, Ribera JM, Sanz MA, PETHA Cooperative Group, Spain.
    Haematologica; 2001 Aug 20; 86(8):807-13. PubMed ID: 11522536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.